Skip to main content
SpringerLink
Log in

Sympathoinhibition by rilmenidine in conscious rabbits: involvement of α2-adrenoceptors

  • Original Articles
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Cardiovascular and sympathetic nervous system effects of the mixed α2-adrenoceptor and imidazoline receptor agonist rilmenidine were studied in conscious rabbits chronically instrumented for the recording of the firing rate of renal sympathetic fibers. Separate experiments were carried out on pithed rabbits with electrically stimulated (2 Hz) sympathetic outflow. Drugs were administered intravenously in a cumulative manner.

In conscious rabbits, rilmenidine 0.1, 0.3 and 1.0 mg kg−1 dose-dependently lowered blood pressure, renal sympathetic nerve activity, heart rate and the plasma concentration of noradrenaline and adrenaline. The effect on blood pressure and plasma catecholamines was maximal after 0.3 mg kg−1 whereas heart rate and renal sympathetic nerve activity decreased further after rilmenidine 1.0 mg kg−1. Yohimbine 0.1 and 0.5 mg kg−1, when injected subsequently, attenuated and at the higher dose abolished all effects of rilmenidine. The effects of rilmenidine were also antagonized by the α2-adrenoceptor antagonist 2-(2,3-dihydro-2-methoxy-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole HCl (RX821002; 0.1 and 0.5 mg kg−1). Yohimbine 0.1 and 0.5 mg kg−1 did not attenuate or attenuated only slightly the decrease of heart rate and renal sympathetic nerve activity produced by infusion of vasopressin. In pithed rabbits with electrically-stimulated sympathetic outflow, yohimbine 0.1 submaximally and yohimbine 0.5 mg kg−1 maximally increased the plasma noradrenaline concentration.

The experiments show by direct measurement of sympathetic nerve firing and plasma catecholamines that rilmenidine causes sympathoinhibition in conscious rabbits, presumably through central sites of action. The antagonism by yohimbine, at doses which are selective for α2-adrenoceptors (vs. imidazoline receptors), demonstrates the involvement of α2-adrenoceptors in the sympatho-inhibition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bousquet P, Feldman J, Schwartz J (1984) Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther 230:232–236

    Google Scholar 

  • Bricca G, Dontenwill M, Molines A, Feldman J, Belcourt A, Bousquet P (1989) The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. Eur J Pharmacol 162:1–9

    Google Scholar 

  • Dorward PK, Riedel W, Burke SL, Gipps J, Korner PI (1985) The renal sympathetic baroreflex in the rabbit. Arterial and cardiac baroreceptor influences, resetting, and effect of anesthesia. Circ Res 57:618–633

    Google Scholar 

  • Ernsberger P, Meeley MP, Mann JJ, Reis DJ (1987) Clonidine binds to imidazole binding sites as well as α2-adrenoceptors in the ventrolateral medulla. Eur J Pharmacol 134:1–13

    Google Scholar 

  • Ernsberger P, Giuliano R, Willette RN, Reis DJ (1990) Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther 253:408–418

    Google Scholar 

  • Ernsberger PR, Westbrooks KL, Christen MO, Schafer SG (1992) A second generation of centrally acting antihypertensive agents act on putative I1-imidazoline receptors. J Cardiovasc Pharmacol 20 [Suppl 4]:S1-S10

    Google Scholar 

  • Ernsberger P, Damon TH, Graff LM, Schafer SG, Christen MO (1993) Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites. J Pharmacol Exp Ther 264:172–182

    Google Scholar 

  • Feldman J, Tibiriça E, Bricca G, Dontenwill M, Belcourt A, Bousquet P (1990) Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit. Br J Pharmcol 100:600–604

    Google Scholar 

  • Fuder H, Schwarz P (1993) Desensitization of inhibitory prejunctional α2-adrenoceptors and putative imidazoline/guanidine sensitive receptors on rabbit heart sympathetic nerves. Naunyn-Schmiedeberg's Arch Pharmacol 348:127–133

    Google Scholar 

  • Gomez RE, Ernsberger P, Feinland G, Reis DJ (1991) Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. Eur J Pharmacol 195:181–191

    Google Scholar 

  • Göthert M, Molderings GJ (1991) Involvement or presynaptic imidazoline receptors in the α2-adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives. Naunyn-Schmiedeberg's Arch Pharmacol 343:271–282

    Google Scholar 

  • Häusler G (1982) Central α-adrenoceptors involved in cardiovascular regulation. J Cardiovasc Pharmacol 4 [Suppl 1]:S72-S76

    Google Scholar 

  • Hamilton CA (1992) Adrenergic and nonadrenergic effects of imidazoline and related antihypertensive drugs in the brain and periphery. Am J Hypertens 5:58S-63S

    Google Scholar 

  • Hamilton CA, Yakubu MA, Jardine E, Reid JL (1991) Imidazoline binding sites in rabbit kidney and forebrain membranes. J Auton Pharmacol 11:277–283

    Google Scholar 

  • Head GA, Burke S (1991) Importance of central noradrenergic and serotonergic pathways in the cardiovascular actions or rilmenidine and clonidine. J Cardiovasc Pharmacol 18:819–826

    Google Scholar 

  • Head GA, Sannajust F (1992) Importance of imidazoline receptors in the cardiovascular responses to clonidine and rilmenidine in conscious rabbits. Fundam Clin Pharmacol 6 [Suppl 1]:31s-34s

    Google Scholar 

  • Hubbard JW, Pfister SL, Biediger AM, Herzig TC, Keeton TK (1988) The pharmacokinetic properties of yohimbine in the conscious rat. Naunyn-Schmiedeberg's Arch Pharmacol 337:583–587

    Google Scholar 

  • Kobinger W (1967) Über den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit Imidazolinstruktur. Naunyn-Schmiedebergs Arch Pharmak exp Path 258:48–58

    Google Scholar 

  • Kobinger W (1978) Central α-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 81:40–100

    Google Scholar 

  • Kobinger W (1986) Drugs as tools in research on adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 332:113–123

    Google Scholar 

  • Koenig-Berard E, Tierney C, Beau B, Delbarre G, Lhoste F, Labrid C (1988) Cardiovascular and central nervous system effects of rilmenidine (S 3341) in rats. Am J Cardiol 61:22D-31D

    Google Scholar 

  • Laubie M, Poignant JC, Scuvée-Moreau J, Dabire H, Dresse A, Schmitt H (1985) Pharmacological properties of (N-dicyclopropylmethyl) amino-2-oxazoline (S3341), an α2 adrenoceptor agonist. J Pharmacol (Paris) 16:259–278

    Google Scholar 

  • Laurent S, Safar M (1992) Rilmenidine: a novel approach to first-line treatment of hypertension. Am J Hypertens 5:99S-105S

    Google Scholar 

  • Majewski H, Hedler L, Starke K (1983) Modulation of noradrenaline release in the conscious rabbit through α-adrenoceptors. Eur J Pharmacol 93:255–264

    Google Scholar 

  • McAuley MA, Reid JL, Macrae IM (1992) Central cardiovascular effects of rilmenidine and neuropeptide Y in the conscious spontaneously hypertensive rat: haemodynamic and biochemical evidence for a negative interaction. J Cardiovase Pharmacol 19:945–952

    Google Scholar 

  • Molderings GJ, Hentrich F, Göthert M (1991) Pharmacological characterization of the imidazoline receptor which mediates inhibition of noradrenaline release in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 344:630–638

    Google Scholar 

  • Sannajust F, Barrès, Koenig-Bérard E, Sassard J (1992a) Sympathoinhibitory effects of rilmenidine may be mediated by sites located below the brainstem. Br J Pharmacol 105:535–541

    Google Scholar 

  • Sannajust F, Cerutti C, Koenig-Bérard E, Sassard J (1992b) Influence of anaesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats. Br J Pharmacol 105:542–548

    Google Scholar 

  • Senard JM, Langin D, Estan L, Paris H (1990) Identification of α2-adrenoceptors and non-adrenergic idazoxan binding sites in rabbit colon epithelial cells. Eur J Pharmacol 191:59–68

    Google Scholar 

  • Simonneaux V, Ebadi M, Bylund DB (1991) Identification and characteriztion of α2D-adrenergic receptors in bovine pineal gland. Mol Pharmacol 40:235–241

    Google Scholar 

  • Spiers JP, Harron DWG, Wilson R (1990) Acute and chronic effects of rilmenidine on baroreflex function in conscious dogs. Eur J Pharmacol 181:235–240

    Google Scholar 

  • Starke K, Borowski E, Endo T (1975) Preferential blockade of presynaptic α-adrenoceptors by yohimbine. Eur J Pharmacol 34:385–388

    Google Scholar 

  • Starke K, Gothert M, Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69:864–989

    Google Scholar 

  • Szabo B, Hedler L, Lichtwald K, Starke K (1987) ACTH increases noradrenaline release in pithed rabbits with electrically stimulated sympathetic outflow. Eur J Pharmacol 136:391–399

    Google Scholar 

  • Szabo B, Hedler L, Starke K (1989) Peripheral presynaptic and central effects of clonidine, yohimbine and rauwolscine on the sympathetic nervous system in rabbits. Naunyn-Schmiedeberg's Arch Pharmacol 340:648–657

    Google Scholar 

  • Szabo B, Schultheiss A (1990) Desipramine inhibits sympathetic nerve activity in the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 342:469–476

    Google Scholar 

  • Szabo B, Schultheiss A, Starke K (1991) The noradrenaline uptake inhibitor, (+)-oxaprotiline, but not the inactive enantiomer, (−)oxaprotiline, inhibits sympathetic nerve activity in the rabbit: involvement of adrenoceptors. Eur J Pharmacol 199:325–334

    Google Scholar 

  • Szabo B, Schramm A, Starke K (1992) Effect of yohimbine on renal sympathetic nerve activity and renal norepinephrine spillover in anesthetized rabbits. J Pharmacol Exp Ther 260:780–788

    Google Scholar 

  • Szabo B, Auberle T, Starke K (1993) Inhibition of uptake, by (+)-oxaprotiline reveals a differential central regulation of noradrenaline and adrenaline release. Naunyn-Schmiedeberg's Arch Pharmacol 348:249–257

    Google Scholar 

  • Tibiriça E, Feldman J, Mermet C, Monassier L, Gonon F, Bousquet P (1991) Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors. Eur J Pharmacol 209:213–221

    Google Scholar 

  • Trendelenburg AU, Limberger N, Starke K (1993) Presynaptic α2-autoreceptors in brain cortex: α2D in the rat and α2A in the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 348:35–45

    Google Scholar 

  • Valet P, Tran MA, Damase-Michel C, de Saint-Blanquardt G, Tran DL, Anglade F, Koenig-Berard E, Montastruc JL (1988) Rilmenidine (S 3341) and the sympathoadrenal system: adrenoceptors, plasma and adrenal catecholamines in dogs. J Auton Pharmacol 8:319–326

    Google Scholar 

  • Van Zwieten PA, Thoolen MJMC, Jonkman FAM, Wilffert B, De Jonge A, Timmermans PBMWM (1986) Central and peripheral effects of S 3341 [(N-dicyclopropylmethyl)-amino-2-oxazoline] in animal models. Arch Int Pharmacodyn Ther 279:130–149

    Google Scholar 

  • Verbeuren TJ, Jordaens FH, Zonnekeyn LL, Herman AG (1986) Effect of the amino-oxazoline derivative S-3341 on pre- and postjunctional α-adrenoceptors in isolated blood vessels. Arch Int Pharmacodyn Ther 284:38–52

    Google Scholar 

  • Verbeuren TJ, Xuan ATD, Koenig-Berard E, Vitou P (1990) Rihnenidine. Cardiovasc Drug Rev 8:56–70

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmakologisches Institut der Albert-Ludwigs-Universïtat, Hermann-Herder-Strasse 5, D-79104, Freiburg i. Br., Germany

    Bela Szabo, Rolf Urban & Klaus Starke

Authors
  1. Bela Szabo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rolf Urban
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Klaus Starke
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Correspondence to: B. Szabo at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Szabo, B., Urban, R. & Starke, K. Sympathoinhibition by rilmenidine in conscious rabbits: involvement of α2-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 348, 593–600 (1993). https://doi.org/10.1007/BF00167235

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00167235

Key words

Search

Navigation